Current Oncology, Volume 25, Issue 2

The paper “Connecting people with cancer to physical activity and exercise programs: a pathway to create accessibility and engagement” is very timely. [...]

Background: Clinical trials are vital for evidence-based cancer care. Oncologist engagement in clinical trials has an effect on patient recruitment, which in turn can affect trial success. Identifying barriers to clinical trial participation might en...

Background: Overuse of surveillance imaging in patients after curative treatment for early breast cancer (EBC) was recently identified as one of the Choosing Wisely Canada initiatives to improve the quality of cancer care. We undertook a population-l...

Purpose: The mainstay of treatment for ductal carcinoma in situ (DCIS) involves surgery in the form of mastectomy or lumpectomy. Inconsistency in the use of endocrine therapy (ET) for DCIS is evident worldwide. We sought to assess the variation in ET...

This article reviews intravenous vitamin C (IV C) in cancer care and offers a rational approach to enable medical oncologists and integrative practitioners to safely provide IV C combined with oral vitamin C to patients. The use of IV C is a safe sup...

Recent guidelines concerning exercise for people with cancer provide evidence-based direction for exercise assessment and prescription for clinicians and their patients. Although the guidelines promote exercise integration into clinical care for peop...

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIS) are recommended as first-line systemic therapy for patients with non-small-cell lung cancer (NSCLC) having mutations in the EGFR gene. Resistance to TKIS eventually occurs in a...

Three groups of men are at high risk of developing prostate cancer: men with a strong family history of prostate cancer, men of West African or Caribbean ancestry, and men with a germline pathogenic variant in a prostate cancer–associated gene. Despi...

Patient-reported outcomes measures (PROMS) are an important component of the shift from disease-centred to person-centred care. In oncology, PROMS describe the effects of cancer and its treatment from the patient perspective and ideally enable patien...

Background: The neutrophil–lymphocyte ratio (NLR) has been reported to correlate with patient outcome in several cancers, including breast cancer. We evaluated whether the NLR can be a predictive factor for pathologic complete response (PCR) after ne...